Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Leyland-Jones

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Research|June 1, 1982
Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic diseaseW Kreis, Z Arlin, A Yagoda, et al.
Therapeutic Drug Monitoring|January 1, 1982
Specific determination of pentamethylmelamine and its demethylated metabolites in human plasma by high pressure liquid chromatographyB R Leyland-Jones, P E Deesen, E S Casper, et al.
Archives of Internal Medicine|June 1, 1983
N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal diseaseR L Sherman, D E Drayer, B R Leyland-Jones, et al.
Cancer Treatment Reports|October 1, 1986
Central nervous system toxicity of fludarabine phosphateH G Chun, B R Leyland-Jones, S M Caryk, et al.
Cancer Treatment Reports|July 1, 1987
Azacitidine: 10 years laterA B Glover, B R Leyland-Jones, H G Chun, et al.
Cancer Research|January 15, 1991
Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase geneB R Leyland-Jones, A J Townsend, C P Tu, et al.
Cancer Investigation|January 1, 1985
Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium)A I Einzig, R J Gralla, B R Leyland-Jones, et al.
Journal of Medicinal Chemistry|July 31, 1998
Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and beta-ionylideneacetamidobenzoates with retinoidal activityP Jones, G B Villeneuve, C Fei, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Research|June 1, 1982
Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic diseaseW Kreis, Z Arlin, A Yagoda, et al.
Therapeutic Drug Monitoring|January 1, 1982
Specific determination of pentamethylmelamine and its demethylated metabolites in human plasma by high pressure liquid chromatographyB R Leyland-Jones, P E Deesen, E S Casper, et al.
Archives of Internal Medicine|June 1, 1983
N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal diseaseR L Sherman, D E Drayer, B R Leyland-Jones, et al.
Cancer Treatment Reports|October 1, 1986
Central nervous system toxicity of fludarabine phosphateH G Chun, B R Leyland-Jones, S M Caryk, et al.
Cancer Treatment Reports|July 1, 1987
Azacitidine: 10 years laterA B Glover, B R Leyland-Jones, H G Chun, et al.
Cancer Research|January 15, 1991
Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase geneB R Leyland-Jones, A J Townsend, C P Tu, et al.
Cancer Investigation|January 1, 1985
Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium)A I Einzig, R J Gralla, B R Leyland-Jones, et al.
Journal of Medicinal Chemistry|July 31, 1998
Synthesis and structure-activity relationships of 2-pyrazinylcarboxamidobenzoates and beta-ionylideneacetamidobenzoates with retinoidal activityP Jones, G B Villeneuve, C Fei, et al.
Pageof 1